NM
ABEO icon

Newtyn Management’s Abeona Therapeutics ABEO Stock Holding History

Newtyn Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-248,656
Closed -$1.31M – 33
2025
Q3 		$1.31M Sell
248,656
-231,344
-48% -$1.47M 0.16% 32
2025
Q2 		$2.73M Hold
480,000
– – 0.41% 30
2025
Q1 		$2.28M Buy
480,000
+100,000
+26% +$544K 0.36% 26
2024
Q4 		$2.12M Hold
380,000
– – 0.37% 28
2024
Q3 		$2.4M Hold
380,000
– – 0.37% 31
2024
Q2 		$1.61M Buy
+380,000
New +$1.94M 0.3% 32

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Newtyn Management's ABEO Position: Q4 2025 in Review

Newtyn Management sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 248,656 shares — an estimated $1.31M sold.

Newtyn Management first reported a position in ABEO in Q2 2024 and held it in 6 quarters. The position peaked at $2.73M in Q2 2025. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • Newtyn Management reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Newtyn Management sold 248,656 Abeona Therapeutics shares in Q4 2025, an estimated $1.31M.
  • Newtyn Management first reported a position in Abeona Therapeutics in Q2 2024 and held it in 6 quarters.
  • Newtyn Management's Abeona Therapeutics position peaked at $2.73M in Q2 2025.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on Newtyn Management's 13F filing for Q4 2025, filed 17 Feb 2026.